Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA) (MIMOSA)

This study has been completed.
Information provided by (Responsible Party):
Max Petrov, University of Auckland, New Zealand Identifier:
First received: May 11, 2010
Last updated: January 5, 2013
Last verified: January 2013
Pain relapse during oral refeeding occurs in at least one-fifth of patients with acute pancreatitis. The study hypothesis is that early administered enteral tube feeding might reduce a risk of pain relapse and shorten the length of hospital stay in patients with acute pancreatitis.

Condition Intervention Phase
Acute Pancreatitis
Procedure: Enteral tube feeding
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Early Enteral Tube Feeding Compared With Pancreas Rest in Patients With Acute Pancreatitis: a Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by University of Auckland, New Zealand:

Primary Outcome Measures:
  • Length of hospital stay [ Time Frame: Up to 3 months ]

Secondary Outcome Measures:
  • Pain relapse [ Time Frame: Up to 3 months ]
  • Local and systemic complications [ Time Frame: Up to 3 months ]
  • Feeding intolerance [ Time Frame: Up to 3 months ]
  • Time to solid oral food tolerated [ Time Frame: Approx. one week ]
  • Pain-free time [ Time Frame: Up to 3 months ]
  • Hospital readmission [ Time Frame: Up to 6 months ]
  • Quality of life [ Time Frame: Up to 6 months ]
  • Mortality [ Time Frame: Up to 6 months ]

Enrollment: 35
Study Start Date: May 2010
Study Completion Date: April 2012
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Enteral tube feeding
Nasogastric tube feeding started within 24 h of hospital admission
Procedure: Enteral tube feeding
Nasogastric tube feeding started within 24 h of hospital admission
No Intervention: Nil-per-mouth regimen
Conventional management


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • diagnosis of acute pancreatitis
  • age 18 years or older
  • written informed consent

Exclusion Criteria:

  • > 96 hours after onset of symptoms
  • > 24 hours after hospital admission
  • organ failure by the time of randomization
  • infectious complications before randomization
  • received artificial nutrition before randomization
  • previously enrolled into the trial
  • chronic pancreatitis
  • post-ERCP pancreatitis
  • intraoperative diagnosis of acute pancreatitis
  • pregnancy
  • malignancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01128478

New Zealand
University of Auckland
Auckland, New Zealand
Sponsors and Collaborators
University of Auckland, New Zealand
Principal Investigator: Max Petrov, MD, MPH (Epi) Universioty of Auckland
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Max Petrov, Principal Investigator, University of Auckland, New Zealand Identifier: NCT01128478     History of Changes
Other Study ID Numbers: NTX/08/11/107
Study First Received: May 11, 2010
Last Updated: January 5, 2013

Keywords provided by University of Auckland, New Zealand:
Acute pancreatitis
Enteral nutrition
Pancreas rest

Additional relevant MeSH terms:
Pancreatic Diseases
Digestive System Diseases
Gastrointestinal Agents processed this record on April 26, 2017